The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 18, 2011

Filed:

Mar. 21, 2005
Applicants:

Marcello Allegretti, L'Aquila, IT;

Maria Candida Cesta, L'Aquila, IT;

Riccardo Bertini, L'Aquila, IT;

Marco Mosca, L'Aquila, IT;

Francesco Colotta, L'Aquila, IT;

Inventors:

Marcello Allegretti, L'Aquila, IT;

Maria Candida Cesta, L'Aquila, IT;

Riccardo Bertini, L'Aquila, IT;

Marco Mosca, L'Aquila, IT;

Francesco Colotta, L'Aquila, IT;

Assignee:

Other;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07C 309/65 (2006.01); A61K 31/255 (2006.01); A61K 31/4453 (2006.01); C07D 211/06 (2006.01);
U.S. Cl.
CPC ...
Abstract

4-(trifluoromethanesulfonyloxyphenyl)propionic acid derivatives and pharmaceutical composition containing such compounds are useful in inhibiting the chemotactic activation of neutrophils (PMN leukocytes) induced by the interaction of Interleukin-8 (IL-8) with CXCR1 and CXCR2 membrane receptors. The compounds are used for the prevention and treatment of pathologies deriving from said activation. Notably, these metabolites are devoid of cyclo-oxygenase inhibition activity and are particularly useful in the treatment of neutrophil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bullous pemphigoid, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and in the prevention and treatment of damages caused by ischemia and reperfusion.


Find Patent Forward Citations

Loading…